Videos

Nutritional Priorities to Support GLP-1 Therapy for Obesity

A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

Publication Date: 18 August 2025

Author(s): Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, Bonnet J, Butsch WS, Christensen S, Gianos E, Gulati M, Gupta A, Horn D, Kane RM, Saluja J, Sannidhi D, Stanford FC, Callahan EA

This video highlights expert consensus from four leading organizations on how to optimize nutrition for patients using GLP 1 receptor agonists in obesity care. While these therapies offer meaningful benefits such as significant weight loss and improved metabolic health, patients often face challenges including muscle and bone loss, nutrient deficiencies, and poor adherence. The publication outlines eight practical strategies to support nutritional health, emphasizing a patient-centered approach, baseline nutrition assessment, and structured lifestyle interventions.

Citation: Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, Bonnet J, Butsch WS, Christensen S, Gianos E, Gulati M, Gupta A, Horn D, Kane RM, Saluja J, Sannidhi D, Stanford FC, Callahan EA. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025 Jul;122(1):344-367. doi: 10.1016/j.ajcnut.2025.04.023. Epub 2025 May 30. PMID: 40450457.

READ ARTICLE
Download Transcript (PDF .16 MB)
Category
Adult Disease State